CARLSBAD, Calif., Oct. 26,
2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) announced a live webcast on Wednesday, November 9th at
11:30 a.m. Eastern Time to discuss
its financial results for the third quarter of 2022.
The webcast may be accessed at
A replay will be available for a limited time at the same
About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted
therapy, pioneering new markets and changing standards of care with
its novel antisense technology. Ionis currently has three marketed
medicines and a premier late-stage pipeline highlighted by
industry-leading cardiovascular and neurological franchises. Our
scientific innovation began and continues with the knowledge that
sick people depend on us, which fuels our vision of becoming a
leading, fully integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and follow
us on Twitter @ionispharma.
View original content to download
SOURCE Ionis Pharmaceuticals, Inc.